Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141843 |
| CAS No | NA |
| Mol.F. | C7H7N5O3 |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141844 |
| CAS No | NA |
| Mol.F. | C7H7N5O3 |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141845 |
| CAS No | NA |
| Mol.F. | C7H7N5O3 |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141846 |
| CAS No | NA |
| Mol.F. | C24H19N7O4 |
| Mol.Wt. | 469.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141847 |
| CAS No | NA |
| Mol.F. | C23H18N4O5 |
| Mol.Wt. | 430.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141848 |
| CAS No | NA |
| Mol.F. | C32H42F6N12O15P2S4 |
| Mol.Wt. | 1138.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141849 |
| CAS No | NA |
| Mol.F. | C16H21F3N6O5S2 |
| Mol.Wt. | 498.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141850 |
| CAS No | NA |
| Mol.F. | C11H13F3N6O2S2 |
| Mol.Wt. | 382.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141851 |
| CAS No | NA |
| Mol.F. | C11H12F3N7O3S2 |
| Mol.Wt. | 411.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141852 |
| CAS No | NA |
| Mol.F. | C16H22F3N6O8PS2 |
| Mol.Wt. | 578.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141853 |
| CAS No | NA |
| Mol.F. | C11H13F3N6OS2 |
| Mol.Wt. | 366.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141854 |
| CAS No | NA |
| Mol.F. | C11H12F3N7O2S2 |
| Mol.Wt. | 395.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141855 |
| CAS No | NA |
| Mol.F. | C16H19F3N6Na2O10P2S2 |
| Mol.Wt. | 684.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141856 |
| CAS No | NA |
| Mol.F. | C32H43F6N11O14P2S4 |
| Mol.Wt. | 1109.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141857 |
| CAS No | NA |
| Mol.F. | C17H20Cl2F3N6O14P3S2 : 4(Na) |
| Mol.Wt. | 817.3 : 4(23.0) |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141858 |
| CAS No | NA |
| Mol.F. | C17H24Cl2F3N6O13P3S2 |
| Mol.Wt. | 805.3 |
| INV STATUS | CUSTOM SYNTHESIS |